Clinical trials: Opioid Use, Unspecified With Other Opioid-induced Disorder
Opioid Use, Unspecified With Other Opioid-induced Disorder
Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients
Assessment of pharmacokinetic parameters of once daily subcutaneously administered methylnaltrexone in 10 evaluable neurointensive care patients.
- Trial name
- RELZH12 (NCT01889290)
- Testing
- Methylnaltrexone
- Where
- Switzerland
- Volunteers
- 9 people
- Sponsor
- University of Zurich